⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Lenalidomide in Patients With Chronic Myelomonocytic Leukemia

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Lenalidomide in Patients With Chronic Myelomonocytic Leukemia

Official Title: A Phase I/II Study of Lenalidomide in Patients With Chronic Myelomonocytic Leukemia

Study ID: NCT01368757

Interventions

Revlimid

Study Description

Brief Summary: In a phase I study the investigators plan to investigate safety and toxicity of lenalidomide in patients with Chronic Myelomonocytic Leukemia (CMML). A phase II study will be started once an optimal dose has been found. The primary endpoint will concern the efficacy of lenalidomide in patients with CMML according to the WHO diagnostic criteria.

Detailed Description:

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Krankenhaus d. Barmherzigen Schwestern Linz, Interne I, Linz, Oberösterreich, Austria

Krankenhaus der Elisabethinen Linz GmbH, 1. Interne, Linz, Oberösterreich, Austria

AKH Linz, Innere Medizin 3, Zentrum für Hämatologie und medizinische Onkologie, Linz, Oberösterreich, Austria

Klinikum Wels-Grieskirchen GmbH, IV. Interne Abteilung, Wels, Oberösterreich, Austria

Universitätsklinik f. Innere Medizin Graz, Klinische Abteilung f. Hämatologie, Graz, Steiermark, Austria

Universitätsklinik für Innere Medizin Innsbruck, Klinische Abteilung für Hämatologie und Onkologie, Innsbruck, Tirol, Austria

LKH Feldkirch, Interne E, Feldkirch, Vorarlberg, Austria

Universitaetsklinik der PMU Salzburg, UK f. Innere Medizin III, Salzburg, , Austria

MUW/ AKH Wien Univ. Klinik für Innere Medizin I, Abteilung für Hämatologie und Hämostaseologie, Wien, , Austria

Hanusch Krankenhaus, 3. Med. Abtlg. Für Hämatologie und Onkologie, Wien, , Austria

Contact Details

Name: Josef Thaler, MD

Affiliation: Klinikum Wels-Grieskirchen GmbH

Role: STUDY_DIRECTOR

Name: Sonja Burgstaller, MD

Affiliation: Klinikum Wels-Grieskirchen GmbH

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: